Your browser doesn't support javascript.
loading
Allogeneic transplant following CAR T-cell therapy for large B-cell lymphoma.
Zurko, Joanna; Ramdial, Jeremy; Shadman, Mazyar; Ahmed, Sairah; Szabo, Aniko; Iovino, Lorenzo; Tomas, Ana Alarcon; Sauter, Craig; Perales, Miguel-Angel; Shah, Nirav N; Acharya, Utkarsh H; Jacobson, Caron; Soiffer, Robert J; Wang, Trent; Komanduri, Krishna V; Jaglowski, Samantha; Kittai, Adam S; Denlinger, Nathan; Iqbal, Madiha; Kharfan-Dabaja, Mohamed A; Ayala, Ernesto; Chavez, Julio; Jain, Michael; Locke, Frederick L; Samara, Yazeed; Budde, Lihua E; Mei, Matthew G; Pia, Alexandra Della; Feldman, Tatyana; Ahmed, Nausheen; Jacobs, Ryan; Ghosh, Nilanjan; Dholaria, Bhagirathbhai; Oluwole, Olalekan O; Hess, Brian; Hassan, Ayesha; Kenkre, Vaishalee P; Reagan, Patrick; Awan, Farrukh; Nieto, Yago; Hamadani, Mehdi; Herrera, Alex F.
Affiliation
  • Zurko J; University of Wisconsin Carbone Comprehensive Cancer Center, University of Wisconsin, Madison, WI.
  • Ramdial J; The University of Texas MD Anderson Cancer Center, Department of Stem Cell Transplantation, Division of Cancer Medicine, Houston, TX.
  • Shadman M; Fred Hutchinson Cancer Research Center and University of Washington, Seattle, WA.
  • Ahmed S; The University of Texas MD Anderson Cancer Center, Department of Stem Cell Transplantation, Division of Cancer Medicine, Houston, TX.
  • Szabo A; University of Wisconsin Carbone Comprehensive Cancer Center, University of Wisconsin, Madison, WI.
  • Iovino L; Fred Hutchinson Cancer Research Center and University of Washington, Seattle, WA.
  • Tomas AA; Memorial Sloan Kettering Cancer Center, New York, NY.
  • Sauter C; Memorial Sloan Kettering Cancer Center, New York, NY.
  • Perales MA; Memorial Sloan Kettering Cancer Center, New York, NY.
  • Shah NN; University of Wisconsin Carbone Comprehensive Cancer Center, University of Wisconsin, Madison, WI.
  • Acharya UH; Dana-Farber Cancer Institute, Department of Medical Oncology, Boston, MA.
  • Jacobson C; Dana-Farber Cancer Institute, Department of Medical Oncology, Boston, MA.
  • Soiffer RJ; Dana-Farber Cancer Institute, Department of Medical Oncology, Boston, MA.
  • Wang T; Sylvester Comprehensive Cancer Center, Division of Transplantation and Cellular Therapy, Miami, FL.
  • Komanduri KV; Sylvester Comprehensive Cancer Center, Division of Transplantation and Cellular Therapy, Miami, FL.
  • Jaglowski S; Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University, Columbus, OH.
  • Kittai AS; Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University, Columbus, OH.
  • Denlinger N; Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University, Columbus, OH.
  • Iqbal M; Mayo Clinic, Division of Hematology-Oncology and Blood and Marrow Transplantation and Cellular Therapy Program, Jacksonville, FL.
  • Kharfan-Dabaja MA; Mayo Clinic, Division of Hematology-Oncology and Blood and Marrow Transplantation and Cellular Therapy Program, Jacksonville, FL.
  • Ayala E; Mayo Clinic, Division of Hematology-Oncology and Blood and Marrow Transplantation and Cellular Therapy Program, Jacksonville, FL.
  • Chavez J; H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.
  • Jain M; H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.
  • Locke FL; H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.
  • Samara Y; City of Hope, Department of Hematology and Hematopoietic Cell Transplantation, Duarte, CA.
  • Budde LE; City of Hope, Department of Hematology and Hematopoietic Cell Transplantation, Duarte, CA.
  • Mei MG; City of Hope, Department of Hematology and Hematopoietic Cell Transplantation, Duarte, CA.
  • Pia AD; John Theurer Cancer Center at Hackensack Meridian Health, NJ, USA; Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, NJ.
  • Feldman T; John Theurer Cancer Center at Hackensack Meridian Health, NJ.
  • Ahmed N; University of Kansas Medical Center, Division of Hematologic Malignancies and Cellular Therapeutics, Westwood, KS.
  • Jacobs R; Levine Cancer Institute/Atrium Health, Charlotte, NC.
  • Ghosh N; Levine Cancer Institute/Atrium Health, Charlotte, NC.
  • Dholaria B; Vanderbilt-Ingram Cancer Center, Division of Hematology and Oncology, Nashville, TN.
  • Oluwole OO; Vanderbilt-Ingram Cancer Center, Division of Hematology and Oncology, Nashville, TN.
  • Hess B; Hollings Cancer Center, Medical University of South Carolina, Charleston, SC.
  • Hassan A; University of Wisconsin Carbone Comprehensive Cancer Center, University of Wisconsin, Madison, WI.
  • Kenkre VP; University of Wisconsin Carbone Comprehensive Cancer Center, University of Wisconsin, Madison, WI.
  • Reagan P; Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY.
  • Awan F; Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern, Dallas, TX.
  • Nieto Y; The University of Texas MD Anderson Cancer Center, Department of Stem Cell Transplantation, Division of Cancer Medicine, Houston, TX.
  • Hamadani M; Medical College of Wisconsin, BMT and Cellular Therapy Program, Division of Hematology and Oncology, Milwaukee, WI.
  • Herrera AF; City of Hope, Department of Hematology and Hematopoietic Cell Transplantation, Duarte, CA. aherrera@coh.org.
Haematologica ; 108(1): 98-109, 2023 01 01.
Article in En | MEDLINE | ID: mdl-35833303

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, Large B-Cell, Diffuse / Hematopoietic Stem Cell Transplantation / Receptors, Chimeric Antigen Type of study: Clinical_trials / Observational_studies Limits: Humans Language: En Journal: Haematologica Year: 2023 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, Large B-Cell, Diffuse / Hematopoietic Stem Cell Transplantation / Receptors, Chimeric Antigen Type of study: Clinical_trials / Observational_studies Limits: Humans Language: En Journal: Haematologica Year: 2023 Document type: Article